MBIND
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
BDH Industries Recommended Dividend Of 4 Rupees Per Share
May 17 (Reuters) - BDH Industries Ltd BDHI.BO:
RECOMMENDED DIVIDEND OF 4 RUPEES PER SHARE
Source text for Eikon: ID:nBSEbFz0yT
Further company coverage: BDHI.BO
(([email protected];))
May 17 (Reuters) - BDH Industries Ltd BDHI.BO:
RECOMMENDED DIVIDEND OF 4 RUPEES PER SHARE
Source text for Eikon: ID:nBSEbFz0yT
Further company coverage: BDHI.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
Dividend
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does BDH Inds do?
BDH Industries Limited specializes in Oral Solid Dosages (OSD) technologies with a focus on Novel Drug Delivery System (NDDS). The company's successful products have passed regulatory tests in multiple countries.
Who are the competitors of BDH Inds?
BDH Inds major competitors are Oxygenta Pharma, Syschem (India), Ambalal Sarabhai Ent, Sanjivani Paranteral, Natural Capsules, Aarey Drugs & Pharma, Chemkart India. Market Cap of BDH Inds is ₹240 Crs. While the median market cap of its peers are ₹249 Crs.
Is BDH Inds financially stable compared to its competitors?
BDH Inds seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does BDH Inds pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. BDH Inds latest dividend payout ratio is 27.94% and 3yr average dividend payout ratio is 27.42%
How has BDH Inds allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is BDH Inds balance sheet?
Balance sheet of BDH Inds is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of BDH Inds improving?
The profit is oscillating. The profit of BDH Inds is ₹9.53 Crs for TTM, ₹9.27 Crs for Mar 2025 and ₹9.87 Crs for Mar 2024.
Is the debt of BDH Inds increasing or decreasing?
The net debt of BDH Inds is decreasing. Latest net debt of BDH Inds is -₹61.34 Crs as of Mar-25. This is less than Mar-24 when it was -₹41.58 Crs.
Is BDH Inds stock expensive?
Yes, BDH Inds is expensive. Latest PE of BDH Inds is 25.18, while 3 year average PE is 14.56. Also latest EV/EBITDA of BDH Inds is 17.85 while 3yr average is 9.39.
Has the share price of BDH Inds grown faster than its competition?
BDH Inds has given lower returns compared to its competitors. BDH Inds has grown at ~16.31% over the last 10yrs while peers have grown at a median rate of 19.0%
Is the promoter bullish about BDH Inds?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in BDH Inds is 49.7% and last quarter promoter holding is 49.7%.
Are mutual funds buying/selling BDH Inds?
There is Insufficient data to gauge this.
